Enable job alerts via email!
A biotechnology company in Melbourn seeks a PhD-level candidate to design and optimize qPCR reagents for diagnostic purposes. The ideal candidate will work in a dynamic, fast-paced R&D environment, ensuring compliance with regulatory frameworks. The role offers a collaborative, ambitious culture and an attractive benefits package including private medical insurance and a pension contribution.
This isn’t just lab work, it’s working side by side with biologists, engineers, and production teams to ensure our reagents are robust, reliable, and ready for the real world. You’ll:
We offer a collaborative and ambitious culture, alongside a fantastic benefits package:
LEX Diagnostics was founded in 2020. Our innovative system integrates effortlessly into primary care settings, bringing PCR-level sensitivity to urgent care centres, physician offices, labs, and pharmacies, all at a significantly lower cost per test than other molecular platforms.
2025 is a milestone year: we’ve just submitted dual 510(k) and CLIA waiver applications to the U.S. FDA. We are hopeful for approval. That means you’ll be joining just as we gear up for a major product launch a moment that will have a direct, meaningful impact on your future career.
In December 2023, QuidelOrtho invested in LEX Diagnostics, including an exclusive option to acquire the company following FDA clearance. This strategic partnership means:
We are hopeful for FDA clearance in late 2025 or early 2026, and this will mean transitioning from a nimble start-up, to a globally supported diagnostics leader. Our plans are to do this without losing the curiosity, creativity, and drive that got us here.
Because here, your science really matters. You’ll work on visible, vital problems that directly impact diagnostic accuracy, speed, and usability. You’ll be part of a collaborative, cross-functional team that values deep technical expertise and shared progress. And you’ll help shape how reagents power the future of point-of-care testing.
Let your science take centre stage, and help us build the future of diagnostics.
Apply now.